can you take bpc 157 with tirzepatide Tirzepatide 10MG BPC-157 with GLP-1: Stacking Guide

[31] A large study found that GLP-1 RA use was associated with lower risk of developing immune-mediated inflammatory diseases in patients with type 2 diabetes or obesity, suggesting a potential protective effect in some cohorts.[42] What the science is showing is potential for improvements: GLP-1RAs reduce blunt activation in fibroblast-like synoviocytes and improve joint inflammation and metabolic parameters in rheumatoid arthritis models and small human cohorts.[26][29][25] [31] Early clinical studies and case series in RA patients (especially those with coexisting type 2 diabetes or obesity) reported reduced disease activity scores (DAS28), lower C-reactive protein and erythrocyte sedimentation rate levels, fewer swollen joints, and diminished morning stiffness during GLP-1RA treatment, along with the expected weight reduction and improved insulin sensitivity.[31] Psoriasis showed improved PASI scores and quality-of-life metrics in patients with T2DM and psoriasis, alongside reductions in lesional skin and peripheral TNF-producing monocytes.[26] Case series show meaningful skin improvement.[26] In psoriasis and psoriatic arthritis , GLP-1RA therapy has been associated with improvements in inflammatory markers and disease severity indices

Paul W, Nesamony J, Sharma CP

These data demonstrate dimerization in areas associated with mood, learning, and memory

These include muscle and bone problems, stress and anxiety, and issues in the esophagus, which is the tube that carries food from the mouth to the stomach

Lower food intake, cannabis effects, and diabetes medications can make shakiness, sweating, confusion, dizziness, or anxiety harder to interpret